Chris Ondeck is a partner in the Litigation Department and vice-chair of the Antitrust Group. He focuses his practice on representing clients in civil and criminal antitrust litigation, defending mergers and acquisitions before the U.S. antitrust agencies, defending companies involved in government investigations, and providing antitrust counseling.
Chris has handled antitrust matters for clients in a number of industries, including advertising, aerospace, alcoholic beverages, appliances, building materials, defense, medical devices, metals, mining, natural resources, oil and gas, packaging, pharmaceuticals, software, and telecommunications. He also has developed substantial experience advising clients regarding the application of the antitrust laws to the pharmaceutical industry, the agriculture industry, trade associations, and the energy industry.
Chris also has particular experience with the antitrust issues involving food and agriculture. For more than 20 years, he has represented individual producers, suppliers, marketers, processors, distributors and other market participants. He also has represented many well-known agricultural cooperatives, agriculture industry associations and consumer brands. His experience includes large class actions, arbitrations and government investigations. He is a thought leader in the field, and has published and spoken extensively on the antitrust issues involved. He currently represents clients in the nationwide antitrust class action litigations in the broiler chicken, egg, potato and mushroom industries.
More Legal and Business Bylines From Christopher E Ondeck
- Dr. StrangeGov or: Antitrust Enforcers Should Stop Worrying and Learn to Love Big Business - (Posted On Monday, April 03, 2023)
- Amazon’s Most Favored Nations Policies Scrutinized Under Sherman Act - (Posted On Monday, January 30, 2023)
- Prices and Profits Dominating the News - (Posted On Wednesday, November 16, 2022)
- “Unconscionable” Standard Need Not be Clean Cut: NY Appellate Court Reverses Lysol Price Gouging Case - (Posted On Wednesday, September 14, 2022)
- The Seventh Circuit Asks, “What’s Wrong With Having Lots of Patents" - (Posted On Wednesday, August 10, 2022)
- $264 Million Settlement in EpiPen Price Gouging Litigation - (Posted On Friday, July 29, 2022)
- Infant Formula Shortage Update - (Posted On Wednesday, July 13, 2022)
- FTC Announces Inquiry into the Infant Formula Shortage - (Posted On Wednesday, June 08, 2022)
- Price Gouging Updates: Federal Price Gouging Legislation; Addressing Infant Formula Shortages; Resolution of Online Merchants Guild - (Posted On Friday, May 20, 2022)
- Revisiting Price Gouging Compliance - (Posted On Monday, March 21, 2022)
Christopher E. Ondeck of Proskauer Rose is a National Law Review Go-To Thought Leader for his focus on anticompetitive pricing news, especially related to the Coronavirus pandemic. Mr. Ondeck’s articles examine several price gouging situations arising during the COVID-19 pandemic, ranging from Coronavirus test costs, state price gouging regulations and price gouging restrictions in China. Additionally, Mr. Ondeck breaks down important definitions and tests related to anticompetitive pricing and various defenses to price gouging litigation.